Publications:19
- Home
- Profiles
Mount Sinai DoctorsKristin Meliambro, MD
Nephrology, Internal Medicine
No Patient Experience Ratings
- About Me
- Education & Certifications
- Insurance
- Publications
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Education
MD, Icahn School of Medicine at Mount Sinai
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Nephrology
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. Dennis G. Moledina, Wassim Obeid, Rex N. Smith, Ivy Rosales, Meghan E. Sise, Gilbert Moeckel, Michael Kashgarian, Michael Kuperman, Kirk N. Campbell, Sean Lefferts, Kristin Meliambro, Markus Bitzer, Mark A. Perazella, Randy L. Luciano, Jordan S. Pober, Lloyd G. Cantley, Robert B. Colvin, F. Perry Wilson, Chirag R. Parikh. Journal of Clinical Investigation
- Corrigendum to Novel Treatment Paradigms: Focal Segmental Glomerulosclerosis Kidney International Reports, Volume 8, Issue 1, January 2023, Pages 30–35 (Kidney International Reports (2023) 8(1) (30–35), (S2468024922018162), (10.1016/j.ekir.2022.10.004)). Marina de Cos, Kristin Meliambro, Kirk N. Campbell. Kidney International Reports
- Novel Treatment Paradigms: Focal Segmental Glomerulosclerosis. Marina de Cos, Kristin Meliambro, Kirk N. Campbell. Kidney International Reports
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Meliambro did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.